For cancer patients at the National Cancer Center in Tashkent, every day is a battle to survive their life threatening disease. Lifesaving medicine for patients with aggressive brain cancer can be hard to come by, but thanks to our partner, Merck & Co., Inc., and the government of Uzbekistan, we were able to offer some hope to patients with aggressive brain cancer. The medicines, valued at USD $2.9 million, were donated by Merck & Co., Inc., and will be used at the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology (National Cancer Center) in Tashkent to treat cancer patients from across the country.
The Director of the National Cancer Center Mirzagolib Tillyashaykhov shared what this donation will mean to the community. “This shipment of the donated medication will satisfy the majority of the country’s annual needs in supportive treatment of patients with brain cancer. We are grateful to our American partners for helping us save the lives and improve the health of Uzbekistan citizens.”
Project HOPE has long been dedicated to improving lives in Uzbekistan, and we were especially thrilled to provide to the government of Uzbekistan the medication necessary to treat patients with brain cancer.
For nearly two decades, Project HOPE has facilitated the delivery of more than $106 million in donated pharmaceuticals and medical supplies to Uzbekistan. Our long-standing partnership with the Republic of Uzbekistan Ministry of Health has allowed us to work together to address the country’s health care needs and improve the health of its citizens.
Project HOPE’s commitment to Uzbekistan goes beyond pharmaceuticals and medical supplies delivered as humanitarian aid. We’ve also supported the Republic of Uzbekistan Ministry of Health in implementing effective and targeted interventions to improve maternal and child health and halting the spread of tuberculosis (TB) and HIV.
Currently, Project HOPE, in partnership with the United States Agency for International Development (USAID), is implementing a five-year, $7.6 million USAID TB Control Program that seeks to reduce the burden of tuberculosis in Uzbekistan and prevent multidrug-resistant forms of the disease. The program covers a wide range of activities, including training health care workers to strengthen the health system, improving interagency coordination and cooperation, and increasing access to TB diagnosis and treatment.
We’re committed to improving the lives of people who need medical care in Uzbekistan, and we’ll continue to work with our partners to make that happen.
Get news from the field and updates on how your donations are being put to work.
Read and share stories about Project HOPE with your personal network.